Alerje
David has built and scaled multiple healthcare companies that resulted in successful exits to strategic buyers. As the CEO, he led Armune BioScience in its 2017 acquisition by Exact Sciences. He was the US President at Phadia US/AB, which was sold to Thermo Fisher Scientific in 2011. He is dedicated to developing programs and resources that help people be their best for those they care about most at home, work, and in the community.
This person is not in the org chart
This person is not in any offices
Alerje
Alerje's increasing the overall quality of life of those affected by food allergies by combining the IoMT with a digital health approach.